HBOT Research

Clinical Trial – Feasibility and Efficacy of Enhanced Recovery After Surgery (ERAS) on Length of Stay Among Laparotomy Patients at Mbarara Regional Referral Hospital

The main goal of ERAS is to enhance the recovery of patients, and this has secondary effects,
such reduced length of hospital stay, minimal postoperative complications and lessen
readmission rates. ERAS protocols have been shown to be feasible and safe across the world.
Although it has been shown to be effective in the developed settings and can potentially
reduce the length of hospital stay, and the cost of healthcare in the perioperative period.
The multimodal program of ERAS has been less implemented in the low and middle income African
countries. Studies done outside Uganda (Egypt and South Africa) have demonstrated that ERAS
program can be feasible and yields favorable outcomes in patients.

Hyperbaric oxygen therapy for Alzheimer’s dementia with positron emission tomography imaging: a case report.

Hyperbaric oxygen therapy for Alzheimer’s dementia with positron emission tomography imaging: a case report.

A 58-year-old female was diagnosed with Alzheimer’s dementia (AD) which was rapidly progressive in the 8 months prior to initiation of hyperbaric oxygen therapy (HBOT). Fluorodeoxyglucose (FDG) positron emission tomography (PET) brain imaging demonstrated global and typical metabolic deficits in AD (posterior temporal-parietal watershed and cingulate areas). An 8-week course of HBOT reversed the patient’s symptomatic decline. Repeat PET imaging demonstrated a corresponding 6.5-38% regional and global increase in brain metabolism, including increased metabolism in the typical AD diagnostic areas of the brain. Continued HBOT in conjunction with standard pharmacotherapy maintained the patient’s symptomatic level of function over an ensuing 22 months. This is the first reported case of simultaneous HBOT-induced symptomatic and FDG PET documented improvement of brain metabolism in AD and suggests an effect on global pathology in AD.

Clinical Trial – Adjunctive Hyperbaric Oxygen Therapy (HBOT) for Lower Extermity Diabetic Ulcer:

Diabetic foot ulcers are associated with high risk of amputation. About 50% of patients
undergoing non-traumatic lower limb amputations are diabetics5. The 5-year amputation rate is
estimated to be 19% with a mean time to amputation 58 months since the onset of an diabetic
foot ulcer6.Because infection and tissue hypoxia are the major contributing factors for
non-healing diabetic foot ulcers, hyperbaric oxygen therapy (HBO) carries a potential benefit
for treating these problematic wounds that do not respond to standard therapy.

The role of oxygen in the wound healing cascade and subsequent combatting action against
bacterial invasion, especially anaerobes, is well documented.14 Delayed or arrested healing
and the development of infection is a direct result from decreased perfusion and poor
oxygenation of tissue.15 The presence of wound hypoxia is an major etiological pathway in the
development of chronic non-healing diabetic foot ulcers

Archives

Categories